A translational study for phenotyping and endotyping Chinese patients with NCFBE

Trial Identifier:	D9186R00001
Sponsor:	AstraZeneca
Start Date:	October 2025
Primary Completion Date:	July 2027
Study Completion Date:	July 2027
Condition:	Lungs & Respiratory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China, Shanghai	Shanghai, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.